297 related articles for article (PubMed ID: 16112409)
1. The role of adrenomedullin in angiogenesis.
Ribatti D; Nico B; Spinazzi R; Vacca A; Nussdorfer GG
Peptides; 2005 Sep; 26(9):1670-5. PubMed ID: 16112409
[TBL] [Abstract][Full Text] [Related]
2. Adrenomedullin as a therapeutic target in angiogenesis.
Deville JL; Salas S; Figarella-Branger D; Ouafik L; Daniel L
Expert Opin Ther Targets; 2010 Oct; 14(10):1059-72. PubMed ID: 20846006
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin: angiogenesis and gene therapy.
Nagaya N; Mori H; Murakami S; Kangawa K; Kitamura S
Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1432-7. PubMed ID: 15886352
[TBL] [Abstract][Full Text] [Related]
4. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.
Fernandez-Sauze S; Delfino C; Mabrouk K; Dussert C; Chinot O; Martin PM; Grisoli F; Ouafik L; Boudouresque F
Int J Cancer; 2004 Mar; 108(6):797-804. PubMed ID: 14712479
[TBL] [Abstract][Full Text] [Related]
5. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review.
Ribatti D
Br J Haematol; 2005 Feb; 128(3):303-9. PubMed ID: 15667531
[TBL] [Abstract][Full Text] [Related]
6. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
Ferrara N
Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
[TBL] [Abstract][Full Text] [Related]
7. Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2.
Guidolin D; Albertin G; Spinazzi R; Sorato E; Mascarin A; Cavallo D; Antonello M; Ribatti D
Peptides; 2008 Nov; 29(11):2013-23. PubMed ID: 18692535
[TBL] [Abstract][Full Text] [Related]
8. Nonclassic endogenous novel [corrected] regulators of angiogenesis.
Ribatti D; Conconi MT; Nussdorfer GG
Pharmacol Rev; 2007 Jun; 59(2):185-205. PubMed ID: 17540906
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-regulated angiogenic inhibitors.
Messmer-Blust A; An X; Li J
Trends Cardiovasc Med; 2009 Nov; 19(8):252-6. PubMed ID: 20447566
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cell biology: an update. 5th International Symposium on the Biology of Endothelial Cells.
Morawietz H; Breier G
Thromb Haemost; 2006 Jun; 95(6):1025-30. PubMed ID: 16732383
[TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis.
Ishikawa T; Chen J; Wang J; Okada F; Sugiyama T; Kobayashi T; Shindo M; Higashino F; Katoh H; Asaka M; Kondo T; Hosokawa M; Kobayashi M
Oncogene; 2003 Feb; 22(8):1238-42. PubMed ID: 12606950
[TBL] [Abstract][Full Text] [Related]
12. Involvement of adrenomedullin induced by hypoxia in angiogenesis in human renal cell carcinoma.
Fujita Y; Mimata H; Nasu N; Nomura T; Nomura Y; Nakagawa M
Int J Urol; 2002 Jun; 9(6):285-95. PubMed ID: 12110091
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin and tumour angiogenesis.
Nikitenko LL; Fox SB; Kehoe S; Rees MC; Bicknell R
Br J Cancer; 2006 Jan; 94(1):1-7. PubMed ID: 16251875
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
15. [VEGF, anti-vEGF and diseases].
Corvol P
Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic effects of adrenomedullin in ischemia and tumor growth.
Iimuro S; Shindo T; Moriyama N; Amaki T; Niu P; Takeda N; Iwata H; Zhang Y; Ebihara A; Nagai R
Circ Res; 2004 Aug; 95(4):415-23. PubMed ID: 15242974
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia: a key regulator of angiogenesis in cancer.
Liao D; Johnson RS
Cancer Metastasis Rev; 2007 Jun; 26(2):281-90. PubMed ID: 17603752
[TBL] [Abstract][Full Text] [Related]
19. [Role of adrenomedullin in glioblastomas growth].
Boudouresque F; Berthois Y; Martin PM; Figarella-Branger D; Chinot O; Ouafik L
Bull Cancer; 2005 Apr; 92(4):317-26. PubMed ID: 15888388
[TBL] [Abstract][Full Text] [Related]
20. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
